These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Immunosuppressive treatment about the patient operated facial allotransplantation in perioperative period].
    Author: Zhang XD, Guo SZ, Han Y, Lu BL, Wen AD, Yang L, Zhang H, Wang DT, Liu YJ, Fan X.
    Journal: Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May; 23(3):183-6. PubMed ID: 17649932.
    Abstract:
    OBJECTIVE: To investigate the perioperation medication on the first patient who was operated facial allotransplantation, including immunosuppressive drug and adjunctive drug, so that to search a effective medication schedule to the patient operated facial allotransplantation. METHODS: FK506, MMF, Prednisone and Zenapax was performed as immunosuppressive regiment in perioperative treatment; meanwhile, anti-infectives was administered to take precautions against all sorts of infections, such as bacterium, virus and fungus. Furthermore, all kinds of adjunctive drug, Losec, glucurolactone and so on, was administered to protect those function of stomach, liver, kidney and so on. Clinical observations were made on the signs and symptoms of graft survival or rejection, as well as immunological indexes were tested in laboratory. Biopsies of graft were also made at 30 d after operation. Side effect and complication of drug was monitored, in case the body suffered harm. RESULTS: Facial allograft was survived, and the temperature and color of skin were normal. Swelling of tissue was gradually subsidise after 4 days, and recovered in a half month. The count and ratio between Th and Ts were normal, skin Biopsies of every time had no found of hyperacute or acute rejection, and side effect and complication of drug had no monitored. CONCLUSIONS: The regiment of perioperation medication was successfully performed.
    [Abstract] [Full Text] [Related] [New Search]